➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Boehringer Ingelheim
Medtronic
McKinsey
Mallinckrodt

Last Updated: September 18, 2021

DrugPatentWatch Database Preview

Claims for Patent: 5,256,410

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 5,256,410
Title: Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon
Abstract:Human squamous cell carcinoma is successfully treated by intralesional administration of recombinant human interferon alpha-2b.
Inventor(s): Tanner; Daniel J. (Brooklyn, NY), Peets; Edwin A. (New York, NY), Smiles; Kenneth A. (Novato, CA)
Assignee: Schering Corporation (Kenilworth, NJ)
Application Number:07/684,964
Patent Claims:1. A method for treating human squamous cell carcinoma comprising intralesionally administering to a human in need of such treatment a sufficient amount of a purified recombinant human alpha-2 interferon to be effective as an anti-squamous cell carcinoma agent.

2. A method of claim 1 wherein the alpha-2 interferon is recombinant human interferon alfa-2b.

3. A method of claim 1 wherein treatment is effected by administering a dosage of 0.1 to 10.times.10.sup.6 International Units of recombinant human alpha-2 interfereon by injection.

4. A method of claim 1 wherein the dosage is 1.5.times.10.sup.6 International Units.

5. A method of claim 4 wherein the dosage is administered three days a week for three weeks.

Summary for Patent: ⤷  Free Forever Trial

PCT Information
PCT FiledNovember 29, 1989PCT Application Number:PCT/US89/05287
PCT Publication Date:June 14, 1990PCT Publication Number:WO90/06135

Details for Patent 5,256,410

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ⤷  Free Forever Trial Schering Corporation (Kenilworth, NJ) 2010-10-26 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ⤷  Free Forever Trial Schering Corporation (Kenilworth, NJ) 2010-10-26 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ⤷  Free Forever Trial Schering Corporation (Kenilworth, NJ) 2010-10-26 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Mallinckrodt
McKesson
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.